Faculty

Karen J. Wernli

Affiliate Associate Professor, Epidemiology
Affiliate Associate Professor, Health Systems and Population Health

206-287-2934

Education

PhD Epidemiology, University of Washington, 2006
MS Epidemiology, University of Texas, 1998
BS Animal Physiology, University of California (San Diego), 1995

Contact

206-287-2934

1730 Minor Ave., Suite 1600
Seattle, WA 98101
View Website »

Research Interests

Comparative effectiveness research; cancer screening and diagnostic, preventive services, methodology

Recent Publications (PubMed)

A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol.
(2024 Mar 11)
Contemp Clin Trials 140(): 107495
Luce C, Palazzo L, Anderson ML, Carter-Bawa L, Gao H, Green BB, Ralston JD, Rogers K, Su YR, Tuzzio L, Triplette M, Wernli KJ

Predicting five-year interval second breast cancer risk in women with prior breast cancer.
(2024 Mar 11)
J Natl Cancer Inst
Hubbard RA, Su YR, Bowles EJ, Ichikawa L, Kerlikowske K, Lowry KP, Miglioretti DL, Tosteson ANA, Wernli KJ, Lee JM

Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
(2024 Mar 5)
Womens Health Issues
Head M, Cohn B, Wernli KJ, Palazzo L, Ehrlich K, Matson A, Knerr S

Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
(2024 Feb 29)
MMWR Morb Mortal Wkly Rep 73(8): 168-174
Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, Weinberg GA, Selvarangan R, Boom JA, Klein EJ, Halasa NB, Ginde AA, Gibbs KW, Zhu Y, Self WH, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Weber ZA, Yang DH, Ball SW, Surie D, DeCuir J, Dawood FS, Moline HL, Toepfer AP, Clopper BR, Link-Gelles R, Payne AB, Chung JR, Flannery B, Lewis NM, Olson SM, Adams K, Tenforde MW, Garg S, Grohskopf LA, Reed C, Ellington S, CDC Influenza Vaccine Effectiveness Collaborators

Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022.
(2024 Feb 23)
J Infect Dis
Sumner KM, Yadav R, Noble EK, Sandford R, Joshi D, Tartof SY, Wernli KJ, Martin ET, Gaglani M, Zimmerman RK, Talbot HK, Grijalva CG, Belongia EA, Chung JR, Rogier E, Coughlin MM, Flannery B

Show complete publication list